Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1, 2012, Pages 181-186

  Pashapour, Ali ^a   Atalu, Abolfazl ^a   Farhoudi, Mehdi ^a   Taheraghdam, Ali Akbar ^a   Hokmabadi, Elyar Sadeghi ^a   Sharifipour, Ehsan ^a   Najafineshli, Mehdi ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Etiology; Ischemic stroke; Ischemic stroke subtypes; Outcome; Thrombolytic therapy

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MEDICAL HISTORY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PROGNOSIS; RANKIN SCALE; SMOKING; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; UNIVERSITY HOSPITAL;

EID: 84872943586     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.291.2897     Document Type: Article

References (28)

1. Yip TR, Demaerschalk BM. Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada. Stroke. 2007;38(6):1952-1955.
2. American Heart Association: Heart Disease and Stroke Statistics-2004 Update. 2003. Dallas, Texas.
3. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, et al. The greater Cincinnati/Northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29(2):415-421.
4. American Heart Association. Heart and Stroke Facts Statistical-2002 Update. 2001. Dallas.
5. John AM, Robert SH, Ron MW. Rosen's Emergency Medicine: Concepts and Clinical Practice. Mosby Elsevier, Philadelphia, 2006:1631-1634.
6. Smith RW, Scott PA, Grant RJ, Chudnofsky CR, Frederiksen SM. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis. Acad Emerg Med. 1999;6(6):618-625.
7. Judith ET, Gabor DMDK. Emergency Medicine: A Comprehensive Study Guide. McGraw-Hill Professional, North America. 2003:1388.
8. Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol. 2006;63(5):661-664.
9. Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, Hickenbottom S, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell national acute stroke registry. Stroke. 2005;36(6):1232-1240.
10. Demaerschalk BM, Yip TR. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke. 2005;36(11):2500-2503.
11. Demaerschalk BM. Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed. Stroke. 2007;38(8):2215-2216.
12. Saver JL. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke,2007;38(8):2279-2283.
13. Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB. Survey of Emergency Physicians About Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke. Ann Emerg Med. 2005;46(1):56-60.
14. Jauch EC, Cucchiara B, Adeoye O, Meurer W, Brice J, Chan YY, et al. Part 11: Adult stroke: American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 Suppl 3):S818-828.
15. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, et al. A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke. 2007;38(11):2979-2984.
16. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing. 2004;33(2):116-121.
17. Kwan J, Hand P, Sandercock P. Improving the efficiency of delivery of thrombolysis for acute stroke: A systematic review. QJM. 2004;97(5):273-279.
18. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004.61(7):1066-1070.
19. Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (First-Ever and Recurrent) stroke. Stroke. 1999;30(12):2523-2528.
20. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, et al. A prospective communitybased study of stroke in Germany-the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke. 1998;29(12):2501-2506.
21. Walters MR, Muir KW, Harbison J, Lees KR, Ford GA. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Cerebrovasc Dis. 2005;20(6):438-442.
22. Figueroa-Reyes T, Saez MD, Mansilla LE, Sanchez VR, Nogales-Gaete J, Delgado BI. Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean Public Hospital. Rev Med Chil. 2011;139(9):1118-1127.
23. Lovett JK, Coull AJ, Rothwell PM. Early Risk of Recurrence by Subtype of Ischemic Stroke in Population-Based Incidence Studies. Neurology. 2004;62(4):569-573.
24. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735-2740.
25. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31(5):1062-1068.
26. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Determining the incidence of different subtypes of stroke: results from the Perth community stroke study, 1989-1990. Med J Aust. 1993;158(2):85-89.
27. Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick JP, et al. Predicting prognosis after stroke: a placebo group analysis from the national institute of neurological disorders and stroke Rt-PA stroke trial. Neurology. 2000;55(7):952-959.
28. Dharmasaroja PA, Muengtaweepongsa S, Dharmasaroja P. Early Outcome after intravenous thrombolysis in patients with acute ischemic stroke. Neurol India. 2011;59(3):351-354.